Body Contouring Treatments Market: Growth, Size, Share, and Trends

Report Code MD 9199
Published in Jan, 2025, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Body Contouring Treatments Market by Product (System (CT, MRI, Angiography, Mammo), Consumable, Accessories), Type (Single & Dual-head, Syringeless), Application (General Imaging, Interventional), and End user - Global Forecast to 2029

Updated on : January 29, 2025

Overview

The global body contouring treatments market, valued at US$1.33 billion in 2023, is forecasted to grow at a robust CAGR of 10.0%, reaching US$1.46 billion in 2024 and an impressive US$2.58 billion by 2029. A major driver is the growing adoption of minimally invasive and non-invasive body contouring procedures. The increasing demand for aesthetic treatments among male patients has led to the increasing demand for treatments related to body contouring. Moreover, rising disposable income in emerging economies, coupled with expanding access to various healthcare services, supports the demand for body contouring treatments.

Body Contouring Treatments Market – Global Forecast and Key Opportunities to 2029

Attractive Opportunities in the Body Contouring Treatments Market

North America

North America is expected to be lead the market, owing to the high healthcare spending, increase in medical tourism, and technological advancements in body contouring devices.

The market growth globally can be attributed to the rising number of body contouring procedures and the growing adoption of non-invasive and invasive body contouring treatments.

Increasing target population and rising healthcare expenditure may create opportunities for market players in the next five years.

Europe is the second-largest market for body contouring treatments due to rising social media influence.

Emerging economies, such as India and China, offer several opportunities for the growth of the body contouring treatments market.

Global Body Contouring Treatments Market Dynamics

DRIVER: Growing adoption of minimally invasive and non-invasive body contouring procedures

The growing adoption of minimally invasive and non-invasive procedures is a major factor driving the global demand for body contouring procedures. Compared to standard surgical procedures, minimally invasive and non-invasive procedures tend to have several benefits, such as causing less discomfort and scarring and faster recovery. These procedures are less expensive than conventional surgical methods. Therefore, minimally invasive techniques cause fewer complications and potentially lead to similar results as surgery.

RESTRAINT: High cost and lack of reimbursement policy

Premium pricing is a restraining factor for the adoption in emerging countries. The financial cost hinders many potential clients from undergoing these treatments. Thus, the growth rate of the market is slowed because some treatments are no longer accessible and affordable to a larger patient pool. This aspect of finance impacts the demand for procedures and impacts the growth of this market. High treatment costs and lack of a reimbursement policy restrain the body contouring treatments market.

 

OPPORTUNITY: Growth potential in emerging economies

Emerging economies, such as Brazil, Russia, India, and several Latin American and Southeast Asian countries, are expected to offer lucrative growth opportunities to players operating in the body contouring treatments market. Improved healthcare infrastructure and a growing focus on hospital care in these countries would drive the demand and adoption of body contouring devices. The demand for body contouring treatments in these countries has increased due to rapid medical tourism growth, increasing disposable income, and growing awareness about aesthetic specialties.

CHALLENGES: Social and cultural barriers

Social stigmas associated with body contouring treatments (surgical and non-surgical) are due to negative perceptions toward body contouring procedures and religious and ethical concerns related to some treatments, such as alterations of shape. Despite the increasing emphasis on looking younger among the elderly, there are possible negative social consequences related to cosmetic age concealment. The social stigma attached to body contouring treatments negatively affects the social acceptance of these procedures. Privacy concerns prevent open discussions, limiting awareness and increasing stigma.

Global Body Contouring Treatments Market Ecosystem Analysis

The body contouring treatments market has a dynamic ecosystem. The infographic includes all kinds of body contouring device providers, end users, and distributors in the market. The device manufacturers play a crucial role in developing innovative equipment based on various technologies. Distributors facilitate access to this equipment for different end users in the market. The ecosystem helps to streamline the product availability and supply chain.

Body Contouring Treatments Market Ecosystem
 

By technology, the non-invasive technologies segment accounted for the largest share in 2023.

Based on technology, the body contouring treatments market is segmented into invasive technologies and non-invasive technologies. In 2023, the non-invasive technologies segment accounted for the largest market share. Increasing organic and inorganic development strategies by the key players, product launches, and approvals propels the growth of the segment. The launch of innovative products with improved features by key market players also fuels the growth of the body contouring treatments market. A wider range of target population, increased comfort, and affordability of the treatments have led to increased adoption of non-invasive treatments.

By application, the non-surgical fat reduction accounted for the largest share in 2023.

Based on application, the body contouring treatments market is segmented into non-surgical fat reduction, cellulite treatment, liposuction, abdominoplasty, and other applications. In 2023, the non-surgical fat reduction segment accounted for the largest market share. The preference for non-surgical fat reduction procedures has grown due to their convenience and comfort. Elderly individuals seeking non-invasive methods for stubborn fat reduction and younger people seeking preventative therapies also support the growth of this segment.

North America Accounted for the Largest of the Market in 2023

North America accounted for the largest of the market in 2023. The large share of the body contouring treatments market in North America is because the region is attributed to technological leadership, robust healthcare infrastructure, growing funding and grants for developing advanced medical equipment, favorable regulatory scenarios, strategic research collaboration, and a supportive market environment fostering innovations.

HIGHEST CAGR MARKET IN 2023
ASIA_PACIFC FASTEST GROWING MARKET IN THE REGION
Body Contouring Treatments Market Region

Recent Developments of Body Contouring Treatments Market

  • In April 2024, Cynosure LLC (US) merged with Lutronic (South Korea) to provide innovative products and customer service to aesthetic providers.
  • In December 2023, Venus Concept (US) collaborated with Spectra Medical Systems (India) to expand its distribution network and provide customer and technical support.
  • In December 2023, Venus Concept (US) collaborated with Core Aesthetics Skin & Laser Limited (UK) to provide sales, services, and training in the UK.
  • In March 2022, Cynosure LLC (US) and Jeisys Medical Inc. (Japan) partnered to establish the distribution channel for the energy-based laser portfolio of Cynosure in the Japanese market.

Key Market Players

KEY PLAYERS IN THE BODY CONTOURING TREATMENTS MARKET INCLUDE

Want to explore hidden markets that can drive new revenue in Body Contouring Treatments Market?

Scope of the Report

Report Metric Details
Market size available for years 2022-2029
Base Year Considered 2023
Forecast period 2024-2029
Forecast units Value (USD)
Segments covered Technology, patient type, application, end user, and region
Geographies covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

Key Questions Addressed by the Report

The global body contouring treatments market is projected to grow from USD 1.46 billion in 2024 to USD 2.58 billion by 2029, demonstrating a robust CAGR of 10.0%.
The growing adoption of minimally invasive and non-invasive body contouring procedures, as well as increasing demand for aesthetic treatments, especially among male patients, are key factors driving market growth.
The body contouring treatments market is expected to see significant growth in emerging economies like Brazil, Russia, India, and Southeast Asia due to rising disposable income, medical tourism, and expanding healthcare infrastructure.
The high cost of treatments and lack of reimbursement policies are key challenges affecting the growth of the body contouring treatments market, especially in emerging markets.
Non-invasive technologies accounted for the largest share of the body contouring treatments market in 2023, due to their comfort, affordability, and increasing adoption in a wide range of target populations.

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Body Contouring Treatments Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table Of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
26
RESEARCH METHODOLOGY
30
EXECUTIVE SUMMARY
42
PREMIUM INSIGHTS
46
MARKET OVERVIEW
50
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Growing adoption of minimally invasive and non-invasive body contouring procedures
    - Increasing demand for aesthetic treatments among men
    - Rising adoption of new and innovative body contouring technologies
    - Widespread social media influence and cultural changes
    RESTRAINTS
    - High cost of treatment and inadequate reimbursement policies
    OPPORTUNITIES
    - Growth potential in emerging economies
    CHALLENGES
    - Social and cultural barriers
    - Stringent regulatory compliance and safety standards
  • 5.3 VALUE CHAIN ANALYSIS
    RESEARCH & PRODUCT DEVELOPMENT
    RAW MATERIAL PROCUREMENT AND MANUFACTURING
    DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES
  • 5.4 SUPPLY CHAIN ANALYSIS
    MANUFACTURERS
    - Prominent companies
    - Small and medium-sized enterprises
    END USERS
  • 5.5 ECOSYSTEM ANALYSIS
  • 5.6 REGULATORY ANALYSIS
    REGULATORY LANDSCAPE
    - North America
    - Europe
    - Asia Pacific
    - Latin America
    REGULATORY APPROVALS
    KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.7 REIMBURSEMENT SCENARIO ANALYSIS
  • 5.8 INVESTMENT AND FUNDING SCENARIO
  • 5.9 PRICING ANALYSIS
    AVERAGE SELLING PRICE OF KEY PLAYERS, BY TECHNOLOGY
    AVERAGE SELLING PRICE OF BODY CONTOURING DEVICES, BY REGION
  • 5.10 TRADE ANALYSIS
    IMPORT DATA
    EXPORT DATA
  • 5.11 PATENT ANALYSIS
  • 5.12 PORTER’S FIVE FORCES ANALYSIS
    THREAT OF NEW ENTRANTS
    THREAT OF SUBSTITUTES
    BARGAINING POWER OF SUPPLIERS
    BARGAINING POWER OF BUYERS
    INTENSITY OF COMPETITIVE RIVALRY
  • 5.13 KEY STAKEHOLDERS AND BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    KEY BUYING CRITERIA
  • 5.14 KEY CONFERENCES AND EVENTS, 2025–2026
  • 5.15 CASE STUDY ANALYSIS
    IMPROVED FAT REDUCTION PROCEDURES USING LARGER APPLICATOR
    ENHANCED SUPPLY CHAIN AND OPERATIONAL EFFICIENCY WITH HIGHER RESEARCH & DEVELOPMENT
  • 5.16 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - Thermal technologies
    - Non-thermal technologies
    COMPLEMENTARY TECHNOLOGIES
    - Skin cooling systems
    ADJACENT TECHNOLOGIES
    - Treatment planning software
  • 5.17 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • 5.18 UNMET NEEDS
  • 5.19 IMPACT OF AI/GEN AI ON BODY CONTOURING TREATMENTS MARKET
    KEY USE CASES
BODY CONTOURING TREATMENTS MARKET, BY TECHNOLOGY
100
  • 6.1 INTRODUCTION
  • 6.2 INVASIVE TECHNOLOGIES
    INVASIVE RADIOFREQUENCY TECHNOLOGY
    - Growing inclination toward skin tightening to propel market
    INVASIVE LASER TECHNOLOGY
    - Higher advantages compared to traditional techniques to speed up growth
    INVASIVE ULTRASOUND TECHNOLOGY
    - Targeted fat reduction and minimal discomfort to augment growth
  • 6.3 NON-INVASIVE TECHNOLOGIES
    NON-INVASIVE RADIOFREQUENCY TECHNOLOGY
    - Rising use of cellulite treatment, fat reduction, and skin tightening to drive market
    NON-INVASIVE LASER TECHNOLOGY
    - Growing adoption in hospitals and aesthetic clinics to fuel market
    NON-INVASIVE ULTRASOUND TECHNOLOGY
    - Need for precise temperature management control to accelerate growth
    CRYOLIPOLYSIS TECHNOLOGY
    - Low risk and minimal side effects to facilitate growth
    OTHER NON-INVASIVE TECHNOLOGIES
BODY CONTOURING TREATMENTS MARKET, BY GENDER
112
  • 7.1 INTRODUCTION
  • 7.2 FEMALE PATIENTS
    GROWING USE OF BODY CONTOURING TO ADDRESS POST-SURGICAL CHANGES TO BOOST MARKET
  • 7.3 MALE PATIENTS
    INCREASING SHIFT IN SOCIAL AND AESTHETIC STANDARDS TO EXPEDITE GROWTH
BODY CONTOURING TREATMENTS MARKET, BY APPLICATION
117
  • 8.1 INTRODUCTION
  • 8.2 NON-SURGICAL FAT REDUCTION
    GROWING PREFERENCE FOR MINIMALLY INVASIVE PROCEDURES TO FUEL MARKET
  • 8.3 CELLULITE REDUCTION
    RISING OBESITY RATES TO SUPPORT MARKET GROWTH
  • 8.4 LIPOSUCTION
    GROWING DEMAND FOR COSMETIC ENHANCEMENT WITH SHORTER RECOVERY TIMES TO DRIVE MARKET
  • 8.5 ABDOMINOPLASTY
    INCREASING DESIRE FOR AESTHETIC IMPROVEMENTS TO PROMOTE GROWTH
  • 8.6 OTHER APPLICATIONS
BODY CONTOURING TREATMENTS MARKET, BY END USER
124
  • 9.1 INTRODUCTION
  • 9.2 HOSPITALS
    BOOMING MEDICAL TOURISM TO CONTRIBUTE TO MARKET GROWTH
  • 9.3 AESTHETIC CLINICS
    GROWING ESTABLISHMENT OF SPECIALTY CLINICS TO DRIVE MARKET
  • 9.4 MEDICAL SPAS & BEAUTY CENTERS
    RISING FOCUS ON BODY APPEARANCE TO AID GROWTH
BODY CONTOURING TREATMENTS MARKET, BY REGION
129
  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    US
    - Growing public acceptance of body contouring procedures to drive market
    CANADA
    - Rising inclination toward reducing signs of aging to aid growth
  • 10.3 EUROPE
    MACROECONOMIC OUTLOOK FOR EUROPE
    GERMANY
    - Increasing volume of aesthetic procedures to drive market
    FRANCE
    - Increasing demand for age-related aesthetic treatments to spur growth
    UK
    - Rising focus of men on body aesthetics to encourage growth
    ITALY
    - Gowing adoption of surgical procedures among young females to boost market
    SPAIN
    - Growing availability of high-quality and effective products to fuel market
    REST OF EUROPE
  • 10.4 ASIA PACIFIC
    MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    JAPAN
    - Presence of medical aesthetic associations to spur growth
    CHINA
    - Increased availability of cosmetic surgery apps and online services to support growth
    INDIA
    - Increasing disposable income to contribute to market growth
    AUSTRALIA
    - Favorable government initiatives to promote growth
    SOUTH KOREA
    - Rising influx of foreign patients to facilitate growth
    REST OF ASIA PACIFIC
  • 10.5 LATIN AMERICA
    MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    BRAZIL
    - Heightened awareness regarding body contouring enhancements to stimulate growth
    MEXICO
    - Increase in patient inflow from US to sustain growth
    REST OF LATIN AMERICA
  • 10.6 MIDDLE EAST & AFRICA
    GROWING AVAILABILITY OF HIGH-QUALITY TREATMENTS TO DRIVE MARKET
    MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
COMPETITIVE LANDSCAPE
191
  • 11.1 OVERVIEW
  • 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN BODY CONTOURING TREATMENTS MARKET
  • 11.3 REVENUE ANALYSIS, 2019−2023
  • 11.4 MARKET SHARE ANALYSIS, 2023
  • 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS, 2023
    - Company footprint
    - Technology footprint
    - Gender footprint
    - Application footprint
    - End-user footprint
    - Region footprint
  • 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
  • 11.7 COMPANY VALUATION AND FINANCIAL METRICS
    COMPANY VALUATION
    FINANCIAL METRICS
  • 11.8 BRAND/PRODUCT COMPARISON
  • 11.9 COMPETITIVE SCENARIO
    PRODUCT LAUNCHES AND APPROVALS
    DEALS
    EXPANSIONS
COMPANY PROFILES
215
  • 12.1 KEY PLAYERS
    ABBVIE INC.
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    INMODE LTD.
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    BAUSCH HEALTH COMPANIES INC.
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    CYNOSURE LUTRONIC
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    SISRAM MEDICAL LTD
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    CUTERA, INC.
    - Business overview
    - Products offered
    - Recent developments
    EL.EN. S.P.A.
    - Business overview
    - Products offered
    VENUS CONCEPT
    - Business overview
    - Products offered
    - Recent developments
    SHARPLIGHT TECHNOLOGIES INC.
    - Business overview
    - Products offered
    - Recent developments
    SCITON
    - Business overview
    - Products offered
    - Recent developments
    CANDELA CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    BTL INDUSTRIES
    - Business overview
    - Products offered
    - Recent developments
    FOTONA
    - Business overview
    - Products offered
    - Recent developments
    GZ MTS ELECTRONICS CO., LTD.
    - Business overview
    - Products offered
    ROHRER AESTHETICS, INC.
    - Business overview
    - Products offered
    - Recent developments
  • 12.2 OTHER PLAYERS
    GBS INTERNATIONAL HOLDING LTD.
    SINCLAIR
    THERMI
    YOLO MEDICAL INC.
    DOMINION AESTHETIC TECHNOLOGIES, INC.
    ZIMMER MEDIZIN SYSTEME GMBH
    ERCHONIA CORPORATION
    CLASSYS INC.
    WON TECH CO., LTD.
    CELLSOUND AESTHETICS
APPENDIX
263
  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 BODY CONTOURING TREATMENTS MARKET: INCLUSIONS AND EXCLUSIONS
  • TABLE 2 SURGICAL PROCEDURES PERFORMED ON MALE PATIENTS, 2021–2023
  • TABLE 3 NON-SURGICAL PROCEDURES PERFORMED ON MALE PATIENTS, 2021–2023
  • TABLE 4 NUMBER OF SURGICAL PROCEDURES, BY COUNTRY, 2023 (US, GERMANY, FRANCE, GREECE)
  • TABLE 5 NUMBER OF SURGICAL PROCEDURES, BY COUNTRY, 2023 (BELGIUM, MEXICO, COLOMBIA, IRAN)
  • TABLE 6 NUMBER OF SURGICAL PROCEDURES, BY COUNTRY, 2023 (UK, SPAIN, ARGENTINA, PERU)
  • TABLE 7 NON-SURGICAL PROCEDURES, BY COUNTRY, 2023 (GERMANY, FRANCE, BELGIUM, GREECE)
  • TABLE 8 NON-SURGICAL PROCEDURES, BY COUNTRY, 2023 (US, UK, COLOMBIA, IRAN)
  • TABLE 9 NON-SURGICAL PROCEDURES, BY COUNTRY, 2023 (MEXICO, SPAIN, ARGENTINA, PERU)
  • TABLE 10 AESTHETIC PLASTIC SURGEON FEES IN NORTH AMERICA, 2022 VS. 2023
  • TABLE 11 NUMBER OF SURGICAL PROCEDURES, BY COUNTRY, 2023
  • TABLE 12 NUMBER OF SURGICAL PROCEDURES, BY COUNTRY, 2023
  • TABLE 13 NON-SURGICAL PROCEDURES, BY COUNTRY, 2023
  • TABLE 14 NON-SURGICAL PROCEDURES, BY COUNTRY, 2023
  • TABLE 15 BODY CONTOURING TREATMENTS MARKET: ROLE OF COMPANIES IN ECOSYSTEM
  • TABLE 16 US: MEDICAL DEVICE CLASSIFICATION
  • TABLE 17 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
  • TABLE 18 US: CLASSIFICATION OF BODY CONTOURING DEVICES
  • TABLE 19 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
  • TABLE 20 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PHARMACEUTICAL AND MEDICAL DEVICE AGENCY (PMDA)
  • TABLE 21 CHINA: CLASSIFICATION OF MEDICAL DEVICES
  • TABLE 22 REGULATORY APPROVALS FOR BODY CONTOURING DEVICES, BY COUNTRY
  • TABLE 23 NORTH AMERICA: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 24 EUROPE: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 25 ASIA PACIFIC: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 26 LATIN AMERICA: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 27 MIDDLE EAST & AFRICA: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 28 MEDICAL REIMBURSEMENT CODES FOR BODY CONTOURING PROCEDURAL SERVICES IN US, 2023
  • TABLE 29 AVERAGE SELLING PRICE OF KEY PLAYERS, BY TECHNOLOGY, 2024 (USD)
  • TABLE 30 AVERAGE SELLING PRICE OF BODY CONTOURING DEVICES, BY REGION, 2022–2024 (USD)
  • TABLE 31 IMPORT DATA FOR BODY CONTOURING DEVICES (HS CODE 9018), BY COUNTRY, 2019–2023 (USD THOUSAND)
  • TABLE 32 IMPORT DATA FOR LASERS (EXCLUDING LASER DIODES) (HS CODE 901320), BY COUNTRY, 2019–2023 (USD THOUSAND)
  • TABLE 33 EXPORT DATA FOR BODY CONTOURING DEVICES (HS CODE 9018), BY COUNTRY, 2019–2023 (USD THOUSAND)
  • TABLE 34 EXPORT DATA FOR LASER (EXCLUDING LASER DIODES) (HS CODE 901320), BY COUNTRY, 2019–2023 (USD THOUSAND)
  • TABLE 35 INNOVATIONS AND PATENT REGISTRATIONS, JANUARY 2021–AUGUST 2024
  • TABLE 36 BODY CONTOURING TREATMENTS MARKET: PORTER’S FIVE FORCES
  • TABLE 37 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS OF BODY CONTOURING PRODUCTS
  • TABLE 38 INFLUENCE OF END USERS ON BUYING PROCESS, BY END USER
  • TABLE 39 BODY CONTOURING TREATMENTS MARKET: KEY CONFERENCES AND EVENTS, 2025–2026
  • TABLE 40 BRAND MAPPING OF THERMAL TECHNOLOGIES
  • TABLE 41 BRAND MAPPING OF NON-THERMAL TECHNOLOGIES
  • TABLE 42 BODY CONTOURING TREATMENTS MARKET: CURRENT UNMET NEEDS
  • TABLE 43 BODY CONTOURING TREATMENTS MARKET: INTENSITY OF CURRENT UNMET NEEDS
  • TABLE 44 BODY CONTOURING TREATMENTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 45 BODY CONTOURING TREATMENTS MARKET FOR INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 46 BODY CONTOURING TREATMENTS MARKET FOR INVASIVE TECHNOLOGIES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 47 BODY CONTOURING TREATMENTS MARKET FOR INVASIVE RADIOFREQUENCY TECHNOLOGY, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 48 BODY CONTOURING TREATMENTS MARKET FOR INVASIVE LASER TECHNOLOGY, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 49 BODY CONTOURING TREATMENTS MARKET FOR INVASIVE ULTRASOUND TECHNOLOGY, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 50 BODY CONTOURING TREATMENTS MARKET FOR NON-INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 51 BODY CONTOURING TREATMENTS MARKET FOR NON-INVASIVE TECHNOLOGIES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 52 BODY CONTOURING TREATMENTS MARKET FOR NON-INVASIVE RADIOFREQUENCY TECHNOLOGY, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 53 BODY CONTOURING TREATMENTS MARKET FOR NON-INVASIVE LASER TECHNOLOGY, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 54 BODY CONTOURING TREATMENTS MARKET FOR NON-INVASIVE ULTRASOUND TECHNOLOGY, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 55 BODY CONTOURING TREATMENTS MARKET FOR CRYOLIPOLYSIS TECHNOLOGY, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 56 BODY CONTOURING TREATMENTS MARKET FOR OTHER NON-INVASIVE TECHNOLOGIES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 57 BODY CONTOURING TREATMENTS MARKET, BY GENDER, 2022–2029 (USD MILLION)
  • TABLE 58 BODY CONTOURING PROCEDURES IN FEMALE PATIENTS, 2022 VS. 2023
  • TABLE 59 BODY CONTOURING TREATMENTS MARKET FOR FEMALE PATIENTS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 60 BODY CONTOURING PROCEDURES IN MALE PATIENTS, 2022 VS. 2023
  • TABLE 61 BODY CONTOURING TREATMENTS MARKET FOR MALE PATIENTS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 62 BODY CONTOURING TREATMENTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 63 TOP 5 COUNTRIES PERFORMING NON-SURGICAL FAT REDUCTION TREATMENTS, 2018–2023
  • TABLE 64 BODY CONTOURING TREATMENTS MARKET FOR NON-SURGICAL FAT REDUCTION, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 65 BODY CONTOURING TREATMENTS MARKET FOR CELLULITE REDUCTION, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 66 TOP 5 COUNTRIES PERFORMING LIPOSUCTION PROCEDURES, 2018–2023
  • TABLE 67 BODY CONTOURING TREATMENTS MARKET FOR LIPOSUCTION, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 68 TOP 5 COUNTRIES PERFORMING ABDOMINOPLASTY TREATMENTS, 2018–2023
  • TABLE 69 BODY CONTOURING TREATMENTS MARKET FOR ABDOMINOPLASTY, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 70 BODY CONTOURING TREATMENTS MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 71 BODY CONTOURING TREATMENTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 72 BODY CONTOURING TREATMENTS MARKET FOR HOSPITALS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 73 BODY CONTOURING TREATMENTS MARKET FOR AESTHETIC CLINICS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 74 BODY CONTOURING TREATMENTS MARKET FOR MEDICAL SPAS & BEAUTY CENTERS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 75 BODY CONTOURING TREATMENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 76 NORTH AMERICA: BODY CONTOURING TREATMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 77 NORTH AMERICA: BODY CONTOURING TREATMENTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 78 NORTH AMERICA: BODY CONTOURING TREATMENTS MARKET FOR NON-INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 79 NORTH AMERICA: BODY CONTOURING TREATMENTS MARKET FOR INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 80 NORTH AMERICA: BODY CONTOURING TREATMENTS MARKET, BY GENDER, 2022–2029 (USD MILLION)
  • TABLE 81 NORTH AMERICA: BODY CONTOURING TREATMENTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 82 NORTH AMERICA: BODY CONTOURING TREATMENTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 83 KEY MACROINDICATORS FOR NORTH AMERICA
  • TABLE 84 US: BODY CONTOURING TREATMENTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 85 US: BODY CONTOURING TREATMENTS MARKET FOR NON-INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 86 US: BODY CONTOURING TREATMENTS MARKET FOR INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 87 BODY CONTOURING PROCEDURES CONDUCTED IN US, 2020–2023
  • TABLE 88 CANADA: BODY CONTOURING TREATMENTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 89 CANADA: BODY CONTOURING TREATMENTS MARKET FOR NON-INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 90 CANADA: BODY CONTOURING TREATMENTS MARKET FOR INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 91 EUROPE: BODY CONTOURING TREATMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 92 EUROPE: BODY CONTOURING TREATMENTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 93 EUROPE: BODY CONTOURING TREATMENTS MARKET FOR NON-INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 94 EUROPE: BODY CONTOURING TREATMENTS MARKET FOR INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 95 EUROPE: BODY CONTOURING TREATMENTS MARKET, BY GENDER, 2022–2029 (USD MILLION)
  • TABLE 96 EUROPE: BODY CONTOURING TREATMENTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 97 EUROPE: BODY CONTOURING TREATMENTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 98 KEY MACROINDICATORS FOR EUROPE
  • TABLE 99 BODY CONTOURING PROCEDURES CONDUCTED IN GERMANY, 2020–2023
  • TABLE 100 GERMANY: BODY CONTOURING TREATMENTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 101 GERMANY: BODY CONTOURING TREATMENTS MARKET FOR NON-INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 102 GERMANY: BODY CONTOURING TREATMENTS MARKET FOR INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 103 FRANCE: BODY CONTOURING TREATMENTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 104 FRANCE: BODY CONTOURING TREATMENTS MARKET FOR NON-INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 105 FRANCE: BODY CONTOURING TREATMENTS MARKET FOR INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 107 BODY CONTOURING PROCEDURES CONDUCTED IN UK, 2022–2023
  • TABLE 108 UK: BODY CONTOURING TREATMENTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 109 UK: BODY CONTOURING TREATMENTS MARKET FOR NON-INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 110 UK: BODY CONTOURING TREATMENTS MARKET FOR INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 111 BODY CONTOURING PROCEDURES CONDUCTED IN ITALY, 2020–2023
  • TABLE 112 ITALY: BODY CONTOURING TREATMENTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 113 ITALY: BODY CONTOURING TREATMENTS MARKET FOR NON-INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 114 ITALY: BODY CONTOURING TREATMENTS MARKET FOR INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 115 BODY CONTOURING PROCEDURES CONDUCTED IN SPAIN, 2021–2023
  • TABLE 116 SPAIN: BODY CONTOURING TREATMENTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 117 SPAIN: BODY CONTOURING TREATMENTS MARKET FOR NON-INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 118 SPAIN: BODY CONTOURING TREATMENTS MARKET FOR INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 119 REST OF EUROPE: BODY CONTOURING TREATMENTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 120 REST OF EUROPE: BODY CONTOURING TREATMENTS MARKET FOR NON-INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 121 REST OF EUROPE: BODY CONTOURING TREATMENTS MARKET FOR INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 122 ASIA PACIFIC: BODY CONTOURING TREATMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 123 ASIA PACIFIC: BODY CONTOURING TREATMENTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 124 ASIA PACIFIC: BODY CONTOURING TREATMENTS MARKET FOR NON-INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 125 ASIA PACIFIC: BODY CONTOURING TREATMENTS MARKET FOR INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 126 ASIA PACIFIC: BODY CONTOURING TREATMENTS MARKET, BY GENDER, 2022–2029 (USD MILLION)
  • TABLE 127 ASIA PACIFIC: BODY CONTOURING TREATMENTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 128 ASIA PACIFIC: BODY CONTOURING TREATMENTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 129 KEY MACROINDICATORS FOR ASIA PACIFIC
  • TABLE 130 BODY CONTOURING PROCEDURES CONDUCTED IN JAPAN, 2020–2022
  • TABLE 131 JAPAN: BODY CONTOURING TREATMENTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 132 JAPAN: BODY CONTOURING TREATMENTS MARKET FOR NON-INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 133 JAPAN: BODY CONTOURING TREATMENTS MARKET FOR INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 134 CHINA: BODY CONTOURING TREATMENTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 135 CHINA: BODY CONTOURING TREATMENTS MARKET FOR NON-INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 136 CHINA: BODY CONTOURING TREATMENTS MARKET FOR INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 137 BODY CONTOURING PROCEDURES CONDUCTED IN INDIA, 2020–2023
  • TABLE 138 INDIA: BODY CONTOURING TREATMENTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 139 INDIA: BODY CONTOURING TREATMENTS MARKET FOR NON-INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 140 INDIA: BODY CONTOURING TREATMENTS MARKET FOR INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 141 AUSTRALIA: BODY CONTOURING TREATMENTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 142 AUSTRALIA: BODY CONTOURING TREATMENTS MARKET FOR NON-INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 143 AUSTRALIA: BODY CONTOURING TREATMENTS MARKET FOR INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 144 SOUTH KOREA: BODY CONTOURING TREATMENTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 145 SOUTH KOREA: BODY CONTOURING TREATMENTS MARKET FOR NON-INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 146 SOUTH KOREA: BODY CONTOURING TREATMENTS MARKET FOR INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 147 REST OF ASIA PACIFIC: BODY CONTOURING TREATMENTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 148 REST OF ASIA PACIFIC: BODY CONTOURING TREATMENTS MARKET FOR NON-INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 149 REST OF ASIA PACIFIC: BODY CONTOURING TREATMENTS MARKET FOR INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 150 LATIN AMERICA: BODY CONTOURING TREATMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 151 LATIN AMERICA: BODY CONTOURING TREATMENTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 152 LATIN AMERICA: BODY CONTOURING TREATMENTS MARKET FOR NON-INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 153 LATIN AMERICA: BODY CONTOURING TREATMENTS MARKET FOR INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 154 LATIN AMERICA: BODY CONTOURING TREATMENTS MARKET, BY GENDER, 2022–2029 (USD MILLION)
  • TABLE 155 LATIN AMERICA: BODY CONTOURING TREATMENTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 156 LATIN AMERICA: BODY CONTOURING TREATMENTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 157 KEY MACROINDICATORS FOR LATIN AMERICA
  • TABLE 158 BODY CONTOURING PROCEDURES CONDUCTED IN BRAZIL, 2020–2023
  • TABLE 159 BRAZIL: BODY CONTOURING TREATMENTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 160 BRAZIL: BODY CONTOURING TREATMENTS MARKET FOR NON-INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 161 BRAZIL: BODY CONTOURING TREATMENTS MARKET FOR INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 162 MEXICO: BODY CONTOURING TREATMENTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 163 MEXICO: BODY CONTOURING TREATMENTS MARKET FOR NON-INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 164 MEXICO: BODY CONTOURING TREATMENTS MARKET FOR INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 165 BODY CONTOURING PROCEDURES CONDUCTED IN ARGENTINA, 2020–2023
  • TABLE 166 REST OF LATIN AMERICA: BODY CONTOURING TREATMENTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 167 REST OF LATIN AMERICA: BODY CONTOURING TREATMENTS MARKET FOR NON-INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 168 REST OF LATIN AMERICA: BODY CONTOURING TREATMENTS MARKET FOR INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 169 MIDDLE EAST & AFRICA: BODY CONTOURING TREATMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 170 MIDDLE EAST & AFRICA: BODY CONTOURING TREATMENTS MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)
  • TABLE 171 MIDDLE EAST & AFRICA: BODY CONTOURING TREATMENTS MARKET FOR NON-INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 172 MIDDLE EAST & AFRICA: BODY CONTOURING TREATMENTS MARKET FOR INVASIVE TECHNOLOGIES, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 173 MIDDLE EAST & AFRICA: BODY CONTOURING TREATMENTS MARKET, BY GENDER, 2022–2029 (USD MILLION)
  • TABLE 174 MIDDLE EAST & AFRICA: BODY CONTOURING TREATMENTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 175 MIDDLE EAST & AFRICA: BODY CONTOURING TREATMENTS MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 176 KEY MACROINDICATORS FOR MIDDLE EAST & AFRICA
  • TABLE 177 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN BODY CONTOURING TREATMENTS MARKET
  • TABLE 178 BODY CONTOURING TREATMENTS MARKET: DEGREE OF COMPETITION
  • TABLE 179 BODY CONTOURING TREATMENTS MARKET: TECHNOLOGY FOOTPRINT
  • TABLE 180 BODY CONTOURING TREATMENTS MARKET: GENDER FOOTPRINT
  • TABLE 181 BODY CONTOURING TREATMENTS MARKET: APPLICATION FOOTPRINT
  • TABLE 182 BODY CONTOURING TREATMENTS MARKET: END-USER FOOTPRINT
  • TABLE 183 BODY CONTOURING TREATMENTS MARKET: REGION FOOTPRINT
  • TABLE 184 BODY CONTOURING TREATMENTS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 185 BODY CONTOURING TREATMENTS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES
  • TABLE 186 BODY CONTOURING TREATMENTS MARKET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–AUGUST 2024
  • TABLE 187 BODY CONTOURING TREATMENTS MARKET: DEALS, JANUARY 2021–AUGUST 2024
  • TABLE 188 BODY CONTOURING TREATMENTS MARKET: EXPANSIONS, JANUARY 2021–AUGUST 2024
  • TABLE 189 ABBVIE INC.: COMPANY OVERVIEW
  • TABLE 190 ABBVIE INC.: PRODUCTS OFFERED
  • TABLE 191 ABBVIE INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021−AUGUST 2024
  • TABLE 192 INMODE LTD.: COMPANY OVERVIEW
  • TABLE 193 INMODE LTD.: PRODUCTS OFFERED
  • TABLE 194 INMODE LTD.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021− AUGUST 2024
  • TABLE 195 INMODE LTD.: DEALS, JANUARY 2021− AUGUST 2024
  • TABLE 196 BAUSCH HEALTH COMPANIES INC.: COMPANY OVERVIEW
  • TABLE 197 BAUSCH HEALTH COMPANIES INC.: PRODUCTS OFFERED
  • TABLE 198 BAUSCH HEALTH COMPANIES INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021−AUGUST 2024
  • TABLE 199 CYNOSURE LUTRONIC: COMPANY OVERVIEW
  • TABLE 200 CYNOSURE LUTRONIC: PRODUCTS OFFERED
  • TABLE 201 CYNOSURE LUTRONIC: DEALS, JANUARY 2021−AUGUST 2024
  • TABLE 202 SISRAM MEDICAL LTD: COMPANY OVERVIEW
  • TABLE 203 SISRAM MEDICAL LTD: PRODUCTS OFFERED
  • TABLE 204 SISRAM MEDICAL LTD: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021− AUGUST 2024
  • TABLE 205 SISRAM MEDICAL LTD: DEALS, JANUARY 2021−AUGUST 2024
  • TABLE 206 SISRAM MEDICAL LTD: EXPANSIONS, JANUARY 2021−AUGUST 2024
  • TABLE 207 CUTERA, INC.: COMPANY OVERVIEW
  • TABLE 208 CUTERA, INC.: PRODUCTS OFFERED
  • TABLE 209 CUTERA, INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021−AUGUST 2024
  • TABLE 210 EL.EN. S.P.A.: COMPANY OVERVIEW
  • TABLE 211 EL.EN. S.P.A.: PRODUCTS OFFERED
  • TABLE 212 EL.EN. S.P.A.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021−AUGUST 2024
  • TABLE 213 VENUS CONCEPT: COMPANY OVERVIEW
  • TABLE 214 VENUS CONCEPT: PRODUCTS OFFERED
  • TABLE 215 VENUS CONCEPT: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021−AUGUST 2024
  • TABLE 216 VENUS CONCEPT: DEALS, JANUARY 2021−AUGUST 2024
  • TABLE 217 SHARPLIGHT TECHNOLOGIES INC.: COMPANY OVERVIEW
  • TABLE 218 SHARPLIGHT TECHNOLOGIES INC.: PRODUCTS OFFERED
  • TABLE 219 SHARPLIGHT TECHNOLOGIES INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021−AUGUST 2024
  • TABLE 220 SCITON: COMPANY OVERVIEW
  • TABLE 221 SCITON: PRODUCTS OFFERED
  • TABLE 222 SCITON: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021−AUGUST 2024
  • TABLE 223 CANDELA CORPORATION: COMPANY OVERVIEW
  • TABLE 224 CANDELA CORPORATION: PRODUCTS OFFERED
  • TABLE 225 CANDELA CORPORATION: DEALS, JANUARY 2021−AUGUST 2024
  • TABLE 226 BTL INDUSTRIES: COMPANY OVERVIEW
  • TABLE 227 BTL INDUSTRIES: PRODUCTS OFFERED
  • TABLE 228 BTL INDUSTRIES: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021−AUGUST 2024
  • TABLE 229 BTL INDUSTRIES: DEALS, JANUARY 2021−AUGUST 2024
  • TABLE 230 FOTONA: COMPANY OVERVIEW
  • TABLE 231 FOTONA: PRODUCTS OFFERED
  • TABLE 232 FOTONA: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021−AUGUST 2024
  • TABLE 233 GZ MTS ELECTRONICS CO., LTD.: COMPANY OVERVIEW
  • TABLE 234 GZ MTS ELECTRONICS CO., LTD.: PRODUCTS OFFERED
  • TABLE 235 ROHRER AESTHETICS, INC.: COMPANY OVERVIEW
  • TABLE 236 ROHRER AESTHETICS, INC.: PRODUCTS OFFERED
  • TABLE 237 ROHRER AESTHETICS, INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021−AUGUST 2024
  • TABLE 238 ROHRER AESTHETICS, INC.: DEALS, JANUARY 2021−AUGUST 2024
  • TABLE 239 GBS INTERNATIONAL HOLDING LTD.: COMPANY OVERVIEW
  • TABLE 240 SINCLAIR: COMPANY OVERVIEW
  • TABLE 241 THERMI: COMPANY OVERVIEW
  • TABLE 242 YOLO MEDICAL INC.: COMPANY OVERVIEW
  • TABLE 243 DOMINION AESTHETIC TECHNOLOGIES, INC.: COMPANY OVERVIEW
  • TABLE 244 ZIMMER MEDIZINSYSTEME GMBH: COMPANY OVERVIEW
  • TABLE 245 ERCHONIA CORPORATION: COMPANY OVERVIEW
  • TABLE 246 CLASSYS INC.: COMPANY OVERVIEW
  • TABLE 247 WON TECH CO., LTD.: COMPANY OVERVIEW
  • TABLE 248 CELLSOUND AESTHETICS: COMPANY OVERVIEW
LIST OF FIGURES
 
  • FIGURE 1 BODY CONTOURING TREATMENTS MARKET SEGMENTATION
  • FIGURE 2 BODY CONTOURING TREATMENTS MARKET: RESEARCH DESIGN
  • FIGURE 3 BODY CONTOURING TREATMENTS MARKET: KEY PRIMARY SOURCES (DEMAND- AND SUPPLY-SIDE PARTICIPANTS)
  • FIGURE 4 BODY CONTOURING TREATMENTS: KEY INSIGHTS FROM PRIMARY INTERVIEWS
  • FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY- AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 7 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • FIGURE 8 BODY CONTOURING TREATMENTS MARKET SIZE ESTIMATION: COMPANY REVENUE ESTIMATION
  • FIGURE 9 BODY CONTOURING TREATMENTS MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
  • FIGURE 10 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 11 DATA TRIANGULATION METHODOLOGY
  • FIGURE 12 BODY CONTOURING TREATMENTS MARKET, BY TECHNOLOGY, 2024 VS. 2029 (USD MILLION)
  • FIGURE 13 BODY CONTOURING TREATMENTS MARKET, BY GENDER, 2024 VS. 2029 (USD MILLION)
  • FIGURE 14 BODY CONTOURING TREATMENTS MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
  • FIGURE 15 BODY CONTOURING TREATMENTS MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
  • FIGURE 16 BODY CONTOURING TREATMENTS MARKET, BY REGION, 2024–2029 (CAGR)
  • FIGURE 17 GROWING DEMAND FOR MINIMALLY INVASIVE AND NON-INVASIVE PROCEDURES TO DRIVE MARKET
  • FIGURE 18 NON-INVASIVE TECHNOLOGIES SEGMENT TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD
  • FIGURE 19 AESTHETIC CLINICS SEGMENT TO LEAD MARKET DURING FORECAST PERIOD
  • FIGURE 20 ABDOMINOPLASTY SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 21 CHINA TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD
  • FIGURE 22 BODY CONTOURING TREATMENTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 23 NON-SURGICAL PROCEDURES PERFORMED GLOBALLY, 2023 VS. 2022
  • FIGURE 24 BODY CONTOURING TREATMENTS MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 25 BODY CONTOURING TREATMENTS MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 26 BODY CONTOURING TREATMENTS MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 27 PREMARKET NOTIFICATION: 510(K) APPROVALS FOR MEDICAL DEVICES
  • FIGURE 28 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES
  • FIGURE 29 EUROPE: CE APPROVAL PROCESS FOR MEDICAL DEVICES
  • FIGURE 30 INVESTMENT AND FUNDING SCENARIO IN BODY CONTOURING TREATMENTS MARKET, 2019−2023 (USD MILLION)
  • FIGURE 31 NUMBER OF INVESTOR DEALS IN BODY CONTOURING TREATMENTS MARKET, BY KEY PLAYER, 2019−2023 (UNIT)
  • FIGURE 32 VALUE OF INVESTOR DEALS IN BODY CONTOURING TREATMENTS MARKET, BY KEY PLAYER, 2018–2022 (USD MILLION)
  • FIGURE 33 AVERAGE SELLING PRICE OF KEY PLAYERS, BY TECHNOLOGY, 2024
  • FIGURE 34 AVERAGE SELLING PRICE OF BODY CONTOURING DEVICES, BY REGION, 2024
  • FIGURE 35 BODY CONTOURING TREATMENTS MARKET: PATENT ANALYSIS, 2014–2024
  • FIGURE 36 BODY CONTOURING TREATMENTS MARKET: PORTER’S FIVE FORCES ANALYSIS
  • FIGURE 37 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF BODY CONTOURING PRODUCTS
  • FIGURE 38 KEY BUYING CRITERIA, BY END USER
  • FIGURE 39 NEW REVENUE POCKETS FOR PLAYERS IN BODY CONTOURING TREATMENTS MARKET
  • FIGURE 40 MARKET POTENTIAL OF AI/GENERATIVE AI ON BODY CONTOURING TREATMENTS MARKET
  • FIGURE 41 NORTH AMERICA: BODY CONTOURING TREATMENTS MARKET SNAPSHOT
  • FIGURE 42 ASIA PACIFIC: BODY CONTOURING TREATMENTS MARKET SNAPSHOT
  • FIGURE 43 REVENUE ANALYSIS OF TOP PLAYERS IN BODY CONTOURING TREATMENTS MARKET, 2019−2023
  • FIGURE 44 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2023
  • FIGURE 45 RANKING OF KEY PLAYERS IN BODY CONTOURING TREATMENTS MARKET, 2023
  • FIGURE 46 BODY CONTOURING TREATMENTS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 47 BODY CONTOURING TREATMENTS MARKET: COMPANY FOOTPRINT
  • FIGURE 48 BODY CONTOURING TREATMENTS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 49 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 50 EV/EBITDA OF KEY VENDORS
  • FIGURE 51 BODY CONTOURING TREATMENTS MARKET: BRAND/PRODUCT COMPARISON
  • FIGURE 52 ABBVIE INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 53 INMODE LTD.: COMPANY SNAPSHOT (2023)
  • FIGURE 54 BAUSCH HEALTH COMPANIES INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 55 SISRAM MEDICAL LTD: COMPANY SNAPSHOT (2023)
  • FIGURE 56 CUTERA, INC.: COMPANY SNAPSHOT (2023)
  • FIGURE 57 EL.EN. S.P.A.: COMPANY SNAPSHOT (2023)
  • FIGURE 58 VENUS CONCEPT: COMPANY SNAPSHOT (2023)

 

The study involved four major activities in estimating the current size of the body contouring treatments market. Exhaustive secondary research was done to collect information on the market, peer, and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.

Secondary Research

The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial body contouring treatments market study. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various supply and demand sources were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as Chief Executive Officers (CEOs), vice presidents (VPs), marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations in the body contouring treatments market. The primary sources from the demand side include hospitals, aesthetic clinics, medical spas, beauty centers and other end users. Primary research was conducted to validate the market segmentation, identify key players, and gather insights on key industry trends & key market dynamics.

A breakdown of the primary respondents is provided below:

*Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

The tiers of the companies are defined based on their total revenue. As of 2023: Tier 1 => USD 1 billion, Tier 2 = USD 200-500 million to USD 1 billion, and Tier 3 =< USD 200 million

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the body contouring treatments market.These methods were also used extensively to estimate the size of various subsegments in the market . The research metholody used to estimate the market size includes the following:

Data Triangulation

After arriving at the overall market size from the market size estimation process explained above, the body contouring treatments market was split into segments and subsegments. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides. Additionally, the body contouring treatments market was validated using top-down and bottom-up approaches.

Market Definition

Body contouring is a medical process to reshape a body part, which involves removing excess skin, eliminating extra fat, and reforming or sculpting the area. The majority of body parts can be targeted by body contouring. The common sites include arms, buttocks, thighs, back and belly. The products are utilized for multiple applications, including non-surgical fat reduction, liposuction, cellulite treatment, etc. The primary end users of this market are hospitals, aesthetic clinics, medical spas, and beauty centers.

Stakeholders

  • Body Contouring Device Manufacturers
  • Medical Spas and Beauty centers
  • Pharmaceutical Companies
  • Aesthetic Clinics
  • Hospitals
  • Body Contouring Device Distributors and Suppliers
  • Aesthetic Surgeons

Report Objectives

  • To define, describe, and forecast the body contouring treatments market based on technology, application, patient type, end user, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
  • To strategically analyze micro markets with respect to individual growth trends, prospects, and contributions to the total market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the revenue of the market segments with respect to five regions, namely, North America, Europe, the Asia Pacific, Latin America, Middle East and Africa
  • To profile the key players and comprehensively analyze their market ranking and core competencies
  • To benchmark players within the market using a proprietary competitive leadership mapping framework, which analyzes market players on various parameters within the broad categories of  market share and product footprint

Previous Versions of this Report

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Body Contouring Treatments Market

DMCA.com Protection Status